Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.

Published

Journal Article (Review)

Posttraumatic stress disorder (PTSD) is a prevalent and disabling condition. Treatment is essential to reduce symptoms, increase the patient's functioning and well-being, and reduce comorbidity with other psychological disorders. Evidence suggests that psychopharmacologic therapy can be effective in PTSD. This article considers clinical data for various pharmacologic treatment options for PTSD; in particular, several recent studies of selective serotonin reuptake inhibitors are examined. The long-term effects of pharmacotherapy and issues concerning patient management are also discussed.

Full Text

Duke Authors

Cited Authors

  • Davidson, JR

Published Date

  • 2000

Published In

Volume / Issue

  • 61 Suppl 5 /

Start / End Page

  • 52 - 56

PubMed ID

  • 10761679

Pubmed Central ID

  • 10761679

International Standard Serial Number (ISSN)

  • 0160-6689

Language

  • eng

Conference Location

  • United States